Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,netReceivables,longTermDebt,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,netBorrowings,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,currency,epsCurrentYear,market,shortName,exchange,marketState,priceHint,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,exchangeDataDelayedBy,earningsTimestampEnd,epsTrailingTwelveMonths,epsForward,gmtOffSetMilliseconds,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Jun 14, 2021) 4","Short Ratio (Jun 14, 2021) 4","Short % of Float (Jun 14, 2021) 4","Short % of Shares Outstanding (Jun 14, 2021) 4","Shares Short (prior month May 13, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,phone,state,compensationAsOfEpochDate,country,website,maxAge,address1,fax,industry
t0,IRIX,22335000,15625800,1165000,,-2002000,,-2010000,5615000,4939000,-1841000,-1841000,,,,,,8000,11959000,13800000,7020000,-161000,,-2010000,-2010000,2349000,84419000,23910000,25649000,2710000,49559000,165000,-58954000,10756000,965000,19000,77000,27993000,12747000,2185000,19000,1947000,44221000,8185000,312000,7042000,1687000,11777000.0,-5416000.0,9889000.0,1514000.0,9895000.0,16367000.0,-6000.0,64000.0,11830000.0,129000.0,943000.0,-900000.0,366000.0,-73000.0,,31474000,en-US,US,EQUITY,True,Nasdaq Real Time Price,7.16,1630526403,-0.41000032,7.57,7.57,7.05,120262,-26.518517,1.652,6.932857,0.22714281,0.03276323,7.1992755,-0.039275646,-0.0054555,111880728,-31.130434,4.3341403,15,America/New_York,EDT,False,False,USD,-0.27,us_market,IRIDEX Corporation,NGM,PRE,2,-5.4161205,7.05 - 7.57,7.57,0.0,0.0,10,40,finmb_30288,NasdaqGM,IRIDEX Corporation,USD,54151,33300,5.56,3.475,1.6 - 9.71,-2.5500002,-0.2626159,1.6,9.71,1620763200,1636405200,0,1636750800,-0.481,-0.23,-14400000,1.28,,,9.71,1.6,6.93,7.2,54.15k,33.3k,15.63M,,12.76M,28.53%,28.37%,157.22k,3.16,1.13%,1.01%,294.9k,,,,,,0.00%,,,,,"Jan 01, 2021","Apr 02, 2021",-17.02%,-17.24%,-10.52%,-28.58%,39.28M,2.81,32.60%,15.56M,-6.28M,-6.69M,-0.48,,27.99M,1.79,3.94M,15.35,3.47,1.65,10.05M,-22.88k,Value,94043,Healthcare,89,"IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",Mountain View,650 940 4700,CA,1609372800,United States,http://www.iridex.com,86400,1212 Terra Bella Avenue,650 940 4710,Medical Devices
t-1,IRIX,16765000,15625800,887000,,-173000,,-179000,4995000,5582000,-300000,-300000,,,,,,6000,12304000,12604000,6722000,127000,,-179000,-179000,68000,74181000,10603000,17366000,1906000,27969000,148000,-56944000,392000,533000,-19000,132000,11626000,8681000,1249000,-19000,1877000,25359000,7289000,1248000,5714000,1148000,-459000.0,-9000.0,-1000.0,-45000.0,9895000.0,-306000.0,-1000.0,-88000.0,-208000.0,105000.0,1227000.0,-1249000.0,392000.0,-10000.0,,16678000,en-US,US,EQUITY,True,Nasdaq Real Time Price,7.16,1630526403,-0.41000032,7.57,7.57,7.05,120262,-26.518517,1.652,6.932857,0.22714281,0.03276323,7.1992755,-0.039275646,-0.0054555,111880728,-31.130434,4.3341403,15,America/New_York,EDT,False,False,USD,-0.27,us_market,IRIDEX Corporation,NGM,PRE,2,-5.4161205,7.05 - 7.57,7.57,0.0,0.0,10,40,finmb_30288,NasdaqGM,IRIDEX Corporation,USD,54151,33300,5.56,3.475,1.6 - 9.71,-2.5500002,-0.2626159,1.6,9.71,1620763200,1636405200,0,1636750800,-0.481,-0.23,-14400000,1.28,,,9.71,1.6,6.93,7.2,54.15k,33.3k,15.63M,,12.76M,28.53%,28.37%,157.22k,3.16,1.13%,1.01%,294.9k,,,,,,0.00%,,,,,"Jan 01, 2021","Apr 02, 2021",-17.02%,-17.24%,-10.52%,-28.58%,39.28M,2.81,32.60%,15.56M,-6.28M,-6.69M,-0.48,,27.99M,1.79,3.94M,15.35,3.47,1.65,10.05M,-22.88k,Value,94043,Healthcare,89,"IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",Mountain View,650 940 4700,CA,1609372800,United States,http://www.iridex.com,86400,1212 Terra Bella Avenue,650 940 4710,Medical Devices
t-2,IRIX,16647000,15625800,869000,,-1711000,,-1719000,4631000,3654000,-1846000,-1846000,,,,,,8000,8803000,10649000,5149000,135000,,-1719000,-1719000,72000,73837000,11207000,17252000,1254000,28459000,148000,-56765000,407000,533000,32000,149000,11932000,9213000,1526000,32000,2144000,25561000,6083000,971000,7004000,1475000,752000.0,-5000.0,-25000.0,410000.0,9895000.0,308000.0,-25000.0,-72000.0,410000.0,122000.0,877000.0,-325000.0,293000.0,-8000.0,,16348000,en-US,US,EQUITY,True,Nasdaq Real Time Price,7.16,1630526403,-0.41000032,7.57,7.57,7.05,120262,-26.518517,1.652,6.932857,0.22714281,0.03276323,7.1992755,-0.039275646,-0.0054555,111880728,-31.130434,4.3341403,15,America/New_York,EDT,False,False,USD,-0.27,us_market,IRIDEX Corporation,NGM,PRE,2,-5.4161205,7.05 - 7.57,7.57,0.0,0.0,10,40,finmb_30288,NasdaqGM,IRIDEX Corporation,USD,54151,33300,5.56,3.475,1.6 - 9.71,-2.5500002,-0.2626159,1.6,9.71,1620763200,1636405200,0,1636750800,-0.481,-0.23,-14400000,1.28,,,9.71,1.6,6.93,7.2,54.15k,33.3k,15.63M,,12.76M,28.53%,28.37%,157.22k,3.16,1.13%,1.01%,294.9k,,,,,,0.00%,,,,,"Jan 01, 2021","Apr 02, 2021",-17.02%,-17.24%,-10.52%,-28.58%,39.28M,2.81,32.60%,15.56M,-6.28M,-6.69M,-0.48,,27.99M,1.79,3.94M,15.35,3.47,1.65,10.05M,-22.88k,Value,94043,Healthcare,89,"IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",Mountain View,650 940 4700,CA,1609372800,United States,http://www.iridex.com,86400,1212 Terra Bella Avenue,650 940 4710,Medical Devices
t-3,IRIX,18185000,15625800,807000,,-2775000,,-2780000,4383000,2406000,-2784000,-2784000,,,,,,5000,6219000,9003000,3813000,9000,,-2780000,-2780000,76000,73619000,10481000,18794000,1466000,29275000,148000,-55046000,451000,533000,73000,158000,11624000,7575000,1110000,73000,2745000,25763000,5784000,1387000,7847000,557000,-1122000.0,-11000.0,2495000.0,-169000.0,9895000.0,485000.0,-2000.0,-13000.0,-1986000.0,134000.0,313000.0,1143000.0,495000.0,-11000.0,2497000.0,18188000,en-US,US,EQUITY,True,Nasdaq Real Time Price,7.16,1630526403,-0.41000032,7.57,7.57,7.05,120262,-26.518517,1.652,6.932857,0.22714281,0.03276323,7.1992755,-0.039275646,-0.0054555,111880728,-31.130434,4.3341403,15,America/New_York,EDT,False,False,USD,-0.27,us_market,IRIDEX Corporation,NGM,PRE,2,-5.4161205,7.05 - 7.57,7.57,0.0,0.0,10,40,finmb_30288,NasdaqGM,IRIDEX Corporation,USD,54151,33300,5.56,3.475,1.6 - 9.71,-2.5500002,-0.2626159,1.6,9.71,1620763200,1636405200,0,1636750800,-0.481,-0.23,-14400000,1.28,,,9.71,1.6,6.93,7.2,54.15k,33.3k,15.63M,,12.76M,28.53%,28.37%,157.22k,3.16,1.13%,1.01%,294.9k,,,,,,0.00%,,,,,"Jan 01, 2021","Apr 02, 2021",-17.02%,-17.24%,-10.52%,-28.58%,39.28M,2.81,32.60%,15.56M,-6.28M,-6.69M,-0.48,,27.99M,1.79,3.94M,15.35,3.47,1.65,10.05M,-22.88k,Value,94043,Healthcare,89,"IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",Mountain View,650 940 4700,CA,1609372800,United States,http://www.iridex.com,86400,1212 Terra Bella Avenue,650 940 4710,Medical Devices
